$CHRS Income Statement | Understand Stock

$CHRS

$1.07 +$0.06 (5.94%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net revenue
Sales of UDENYCA
Total net revenue
Costs and expenses:
Cost of goods sold
Research and development
Selling, general and administrative
Total costs and expenses
Loss from operations
Interest expense
Gain on Sale Transactions, net (Note 6)
Loss on debt extinguishment
Other income (expense), net
Loss from continuing operations before income taxes
Income tax provision
Net loss from continuing operations
Net income from discontinued operations, net of tax (Note 6)
Net income
Net income (loss) per share:
Net loss from continuing operations - basic
Net loss from continuing operations - diluted
Net income from discontinued operations - basic
Net income from discontinued operations - diluted
Net income per share - Basic (In dollar per share)
Net income per share - Diluted (In dollar per share)
Weighted-average number of shares used in computing net income (loss) per share:
Basic (In shares)
Diluted (In shares)

Comments